Key Words: NSCLC, phase I clinical trials, novel therapies

therapy in NSCLC patients. We investigated the association of all 23 AAbs with anti-PD1 therapy response in NSCLC patients. The concentration of SIX2 AAb before therapy was well correlated with … ................
................

In order to avoid copyright disputes, this page is only a partial summary.